nyo5mmuo | Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/nyo5mmuo_hasAnnotation_C1999216>
?:creator	<https://research.tib.eu/covid-19/entity/Ward%2C_Madison%3B_Gooderham%2C_Melinda>
?:doi	10.1016/j.jdcr.2020.10.032
?:doi	<https://research.tib.eu/covid-19/entity/10.1016/j.jdcr.2020.10.032>
?:journal	JAAD_Case_Rep
?:license	els-covid
?:pdf_json_files	document_parses/pdf_json/85b60ff4a7e7d283bf8cc639ef4359f5b0a0bcab.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7645273>
?:pmid	<https://research.tib.eu/covid-19/entity/33173806.0>
?:pmid	33173806.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/85b60ff4a7e7d283bf8cc639ef4359f5b0a0bcab>
?:source	Elsevier; Medline; PMC
?:title	Asymptomatic SARS-CoV2 infection in a patient receiving risankizumab, an inhibitor of IL-23
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-11-06

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33669713_HAS_TOPIC_C0205847>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33669713_HAS_TOPIC_C0205847>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all